Ishares Us Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since May 21, 2026 Gain 2.43%

The iShares US Pharmaceuticals ETF price gained 0.83% on the last trading day (Monday, 22nd Jun 2026), rising from $91.88 to $92.64. During the last trading day the ETF fluctuated 0.87% from a day low at $92.21 to a day high of $93.01. The price has fallen in 7 of the last 10 days and is down by -0.05% for this period. Volume fell on the last day by -99 thousand shares and in total, 70 thousand shares were bought and sold for approximately $6.45 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the middle of a weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 9.83% during the next 3 months and, with a 90% probability hold a price between $98.63 and $105.32 at the end of this 3-month period.

IHE Signals & Forecast

The iShares US Pharmaceuticals ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $93.46. On a fall, the ETF will find some support from the long-term average at approximately $90.78. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -2.56%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for iShares US Pharmaceuticals ETF

iShares US Pharmaceuticals finds support from accumulated volume at $88.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $0.80 between high and low, or 0.87%. For the last week the ETF has had daily average volatility of 1.65%.

Our recommended stop-loss: $88.90 (-4.04%) (This ETF has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (IHE) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect iShares US Pharmaceuticals ETF to open at $92.62, and during the day (based on 14 day Average True Range), to move between $91.86 and $93.42, which gives a possible trading interval of +/-$1.56 (+/-1.70%) up or down from last closing price. If iShares US Pharmaceuticals ETF takes out the full calculated possible swing range there will be an estimated 1.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $92.83 (0.21%) than the support at $88.43 (4.54%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is iShares US Pharmaceuticals ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for iShares US Pharmaceuticals ETF to perform well in the short-term. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Hold to a Buy candidate.

Current score: 1.142 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $92.62 ( 0.0216%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk